Apolipoprotein A-I and high-density lipoprotein: Is this the beginning of the era of noninvasive angioplasty?

Journal of the American College of Cardiology

Volumn 44, Issue 7, 2004, Pages 1436-1438

  Ballantyne, Christie M ^a,b   Nambi, Vijay ^b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANGIOPLASTY; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE COURSE; FOLLOW UP; GENE MUTATION; GENETIC DISORDER; HETEROZYGOTE; HUMAN; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STATISTICAL SIGNIFICANCE;

EID: 4644312988     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.07.018     Document Type: Editorial

References (17)

1. W.E. Boden High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention trial Am J Cardiol 86 2000 19L 22L
2. D.J. Rader High-density lipoproteins and atherosclerosis Am J Cardiol 90 2002 62i 70i
3. A.M. Gotto Jr., E. Whitney, E.A Stein Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Circulation 101 2000 477 484
4. E.M. Rubin, R.M. Krauss, E.A. Spangler, J.G. Verstuyft, S.M. Clift Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI Nature 353 1991 265 267
5. P. Benoit, F. Emmanuel, J.M Caillaud Somatic gene transfer of human apo A-I inhibits atherosclerosis progression in mouse models Circulation 99 1999 105 110
6. E.J. Schaefer, W.H. Heaton, M.G. Wetzel, H.B. Brewer Jr Plasma apolipoprotein A-I absence associated with a marked reduction of high-density lipoproteins and premature coronary artery disease Arteriosclerosis 2 1982 16 26
7. D.S. Ng, L.A. Leiter, C. Vezina, P.W. Connelly, R.A. Hegele Apolipoprotein A-I Q [-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia J Clin Invest 93 1994 223 229
8. Hovingh GK, Brownlie A, Bisoendial RJ, et al. A novel ApoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. J Am Coll Cardiol 2004;44:1429-35.
9. Milano apoprotein: decreased high-density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family J Clin Invest 66 1980 892 900
10. Milano mutant: the Limone sul Garda study Circulation 103 2001 1949 1954
11. J.M. Ordovas, L.A. Cupples, D Corella Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study Arterioscler Thromb Vasc Biol 20 2000 1323 1329
12. N. Barzilai, G. Atzmon, C Schechter Unique lipoprotein phenotype and genotype associated with exceptional longevity JAMA 290 2003 2030 2040
13. S.E. Nissen, T. Tsunoda, E.M Tuzcu Effect of recombinant Apo A-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2003 2292 2300
14. L.E. Spieker, I. Sudano, D Hurlimann High-density lipoprotein restores endothelial function in hypercholesterolemic men Circulation 105 2002 1399 1402
15. W.V. Rodrigueza, K.D. Mazany, A.D Essenburg Large versus small unilamellar vesicles mediate reverse cholesterol transport in vivo into two distinct hepatic metabolic pools Implications for the treatment of atherosclerosis Arterioscler Thromb Vasc Biol 17 1997 2132 2139
16. M. Navab, G.M. Anantharamaiah, S Hama Oral administration of an apo A-I mimetic peptide synthesized from d-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol Circulation 105 2002 290 292
17. R.W. Clark, T.A. Sutfin, R.B Ruggeri Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib Arterioscler Thromb Vasc Biol 24 2004 490 497